The human metapneumovirus: A case series and review of the literature

Transplant Infectious Disease

Volumn 13, Issue 3, 2011, Pages 324-328

  Shahda, Safi ^a   Carlos, W G ^a   Kiel, P J ^b   Khan, B A ^a   Hage, C A ^a,c  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cellular rejection; Hematopoietic stem cell transplant; Human metapneumovirus; Immunosuppression; Lung transplant; Ribavirin

Indexed keywords

ALEMTUZUMAB; BUSULFAN; CLOFARABINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; IMMUNOGLOBULIN; MELPHALAN; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; RIBAVIRIN; TACROLIMUS; THYMOCYTE ANTIBODY; VIRUS ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; BRONCHOSCOPY; CANCER PATIENT; CASE STUDY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; FEMALE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN METAPNEUMOVIRUS; HUMAN METAPNEUMOVIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; IMMUNOFLUORESCENCE; IMMUNOSUPPRESSIVE TREATMENT; LUNG GRAFT REJECTION; LUNG LAVAGE; LUNG TRANSPLANTATION; MALE; MEDIASTINITIS; MULTIPLE MYELOMA; NONHUMAN; NOSE SMEAR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THORAX RADIOGRAPHY; TREATMENT OUTCOME; VIRUS DETECTION; VIRUS IDENTIFICATION; VIRUS PNEUMONIA;

ADULT; AGED; ANTIVIRAL AGENTS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULINS, INTRAVENOUS; LUNG TRANSPLANTATION; MALE; METAPNEUMOVIRUS; MIDDLE AGED; PARAMYXOVIRIDAE INFECTIONS; RESPIRATORY TRACT INFECTIONS; RIBAVIRIN; TREATMENT OUTCOME;

EID: 79957977434     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2010.00575.x     Document Type: Article

References (17)

1. van den Hoogen BG, de Jong JC, Groen J, et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 2001; 7 (6): 719-724.
2. Raza K, Ismailjee SB, Crespo M, et al. Successful outcome of human metapneumovirus (hMPV) pneumonia in a lung transplant recipient treated with intravenous ribavirin. J Heart Lung Transplant 2007; 26 (8): 862-864.
3. Murali S, Langston AA, Nolte FS, Banks G, Martin R, Caliendo AM. Detection of respiratory viruses with a multiplex polymerase chain reaction assay (MultiCode-PLx Respiratory Virus Panel) in patients with hematologic malignancies. Leuk Lymphoma 2009; 50 (4): 619-624.
4. Larcher C, Geltner C, Fischer H, Nachbauer D, Müller LC, Hueer HP. Human metapneumovirus infection in lung transplant recipients: clinical presentation and epidemiology. J Heart Lung Transplant 2005; 24 (11): 1891-1901.
5. Sharples LD, McNeil K, Stewart S, Wallwork J. Risk factors for bronchiolitis obliterans: a systematic review of recent publications. J Heart Lung Transplant 2002; 21 (2): 271-281.
6. Huck B, Egger M, Bertz H, et al. Human metapneumovirus infection in a hematopoietic stem cell transplant recipient with relapsed multiple myeloma and rapidly progressing lung cancer. J Clin Microbiol 2006; 44 (6): 2300-2303.
7. Peck AJ, Englund JA, Kuypers J, et al. Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection. Blood 2007; 110 (5): 1681-1688.
8. Debiaggi M, Canducci F, Sampaolo M, et al. Persistent symptomless human metapneumovirus infection in hematopoietic stem cell transplant recipients. J Infect Dis 2006; 194 (4): 474-478.
9. Debiaggi M, Canducci F, Terulla C, et al. Long-term study on symptomless human metapneumovirus infection in hematopoietic stem cell transplant recipients. New Microbiol 2007; 30 (3): 255-258.
10. Englund JA, Boeckh M, Kuypers J, et al. Brief communication: fatal human metapneumovirus infection in stem-cell transplant recipients. Ann Intern Med 2006; 144 (5): 344-349.
11. Cane PA, van den Hoogen BG, Chakrabarti S, Fegan CD, Osterhaus D. Human metapneumovirus in a haematopoietic stem cell transplant recipient with fatal lower respiratory tract disease. Bone Marrow Transplant 2003; 31 (4): 309-310.
12. Schildgen O, Glatzel T, Geikowski T, et al. Human metapneumovirus RNA in encephalitis patient. Emerg Infect Dis 2005; 11 (3): 467-470.
13. Safdar A. Immune modulatory activity of ribavirin for serious human metapneumovirus disease: early i.v. therapy may improve outcomes in immunosuppressed SCT recipients. Bone Marrow Transplant 2008; 41 (8): 707-708.
14. Wyde PR, Chetty SN, Jewell AM, Boivin G, Piedra PA. Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro. Antiviral Res 2003; 60 (1): 51-59.
15. Hamelin ME, Prince GA, Boivin G. Effect of ribavirin and glucocorticoid treatment in a mouse model of human metapneumovirus infection. Antimicrob Agents Chemother 2006; 50 (2): 774-777.
16. Kamboj M, Gerbin M, Huang CK, et al. Clinical characterization of human metapneumovirus infection among patients with cancer. J Infect 2008; 57 (6): 464-471.
17. Sookoian S, Castaño G, Flichman D, Cello J. Effects of ribavirin on cytokine production of recall antigens and phytohemaglutinin-stimulated peripheral blood mononuclear cells. (Inhibitory effects of ribavirin on cytokine production). Ann Hepatol 2004; 3 (3): 104-107.